Shahin Tabatabaei

Massachusetts General Hospital, Harvard University

Papers

4

Total Citations

267

H-Index

4

About

Dr. Shahin Tabatabaei is a leading urologic surgeon and researcher whose work sits at the intersection of surgical innovation, patient outcomes, and perioperative safety. His primary research areas include robotic-assisted surgery, comparative effectiveness of prostate cancer treatments, and the physiologic impact of surgical positioning. Dr. Tabatabaei’s most influential contribution is his landmark 2018 comparative study of retropubic, laparoscopic, and robotic radical prostatectomy—cited 174 times—which critically evaluated which approach truly benefits patients. He has also made seminal contributions to understanding respiratory mechanics during robotic surgery, demonstrating how pneumoperitoneum and Trendelenburg positioning affect lung function, with his 2019 randomized study (57 citations) providing quantitative insights into transpulmonary pressure management. His work on patient-reported functional outcomes following prostatectomy (32 citations) has helped shift the field toward patient-centered metrics. Notably, Dr. Tabatabaei also developed and tested the SAF-R patient positioning device, addressing a critical gap in safety for robotic pelvic surgery. His research bridges surgical technique, anesthesiology, and patient quality of life, making him a key voice in the evolution of minimally invasive urologic oncology.

Research Focus

Key Achievements

4
H-Index
4
Papers
267
Total Citations
67
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of retropubic, laparoscopic and robotic radical prostatectomy: who is the winner?
174 citations · 2018
📈 Most Prolific Year: 2015 (2 Papers)
🤝 Key Collaborators: 32
🏛 Institutions: Massachusetts General Hospital, Harvard University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago